IMUX
IMMUNIC, INC.
+0.07 (+0.64%)10.19USD146K成交股數139M市值5.0本益比(近四季)6316.8股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 25.9M | 25.6M | 19.1M | 20.0M | 21.4M | 21.5M | 21.4M | 18.3M | 18.7M | 19.3M | 19.8M | 21.2M |
| 銷售管理費用 | 9.4M | 7.6M | 4.3M | 6.0M | 5.7M | 5.3M | 4.4M | 4.5M | 5.1M | 4.1M | 3.8M | 3.8M |
| 營業利益 | −35.3M+30% | −33.2M+24% | −23.3M-9% | −26.0M+14% | −27.1M+13% | −26.8M+15% | −25.7M+9% | −22.8M-9% | −23.9M | −23.4M | −23.6M | −25.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −34.1M+27% | −32.6M+28% | −19.3M-21% | −25.6M+20% | −26.8M-9% | −25.5M+18% | −24.4M+7% | −21.4M-11% | −29.6M | −21.6M | −22.8M | −24.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.80-61% | -1.08-57% | 4.05-1788% | -0.13-38% | -2.03+577% | -2.51+423% | -0.24-53% | -0.21-61% | -0.30 | -0.48 | -0.51 | -0.54 |
| 稀釋股數 | 42.5M | 30.1M | 156M | 194M | 13.2M | 10.1M | 101M | 101M | 97.3M | 44.3M | 44.6M | 44.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 155M | 187M | 15.5M | 35.1M | 55.3M | 14.3M | 59.1M | 79.7M | 97.3M | 46.7M | 59.7M | 77.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 159M | 190M | 24.1M | 40.7M | 61.4M | 20.5M | 64.8M | 86.5M | 104M | 54.3M | 67.0M | 88.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 31.6M | 38.5M | 30.7M | 30.2M | 27.5M | 25.8M | 23.5M | 22.9M | 20.6M | 25.4M | 18.6M | 19.5M |
| 股東權益 | 128M | 151M | −6.7M | 10.5M | 33.9M | −5.3M | 41.2M | 63.6M | 83.6M | 28.9M | 48.4M | 69.3M |
| 負債比 | 19.8% | 20.3% | 127.7% | 74.2% | 44.8% | 125.8% | 36.4% | 26.5% | 19.8% | 46.7% | 27.7% | 21.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17.3M-21% | – | – | – | −21.8M | – | – | −24.0M | – | – | – |
| 資本支出 | – | 2K | – | – | – | 47K | – | – | 31K | – | – | – |
| 自由現金流 | – | −17.3M-21% | – | – | – | −21.8M | – | – | −24.0M | – | – | – |
| 折舊攤銷 | 34K | 33K | 42K | 40K | 43K | 43K | 42K | 31K | 26K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −97.2M | –% | -0.62 | −86.0M |
| FY2024 | – | – | −101M | –% | -1.00 | −85.0M |
| FY2023 | – | – | −93.6M | –% | -2.11 | −71.2M |
| FY2022 | – | – | −120M | –% | -3.78 | −65.3M |
| FY2021 | – | – | −92.9M | –% | -3.93 | −83.3M |
| FY2020 | – | – | −44.0M | –% | -2.81 | −46.3M |
| FY2019 | – | – | −34.9M | –% | -4.52 | −28.6M |
| FY2018 | – | – | −11.5M | –% | -13.63 | −9.8M |